Sutro Biopharma Inc (NASDAQ: STRO) started the day on Thursday, with a price increase of 12.91% at $0.88, before settling in for the price of $0.78 at the close. Taking a more long-term approach, STRO posted a 52-week range of $0.52-$4.60.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -4.05%. Meanwhile, its Annual Earning per share during the time was -4.05%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 41.25%. This publicly-traded company’s shares outstanding now amounts to $84.72 million, simultaneously with a float of $78.34 million. The organization now has a market capitalization sitting at $74.66 million. At the time of writing, stock’s 50-day Moving Average stood at $0.8764, while the 200-day Moving Average is $1.0678.
Sutro Biopharma Inc (STRO) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Sutro Biopharma Inc’s current insider ownership accounts for 7.60%, in contrast to 59.55% institutional ownership. According to the most recent insider trade that took place on Oct 15 ’25, this organization’s CHIEF SCIENTIFIC OFFICER bought 17,000 shares at the rate of 0.80, making the entire transaction reach 13,607 in total value, affecting insider ownership by 71,832. Preceding that transaction, on Oct 15 ’25, Company’s CFO bought 19,750 for 0.81, making the whole transaction’s value amount to 15,998. This particular insider is now the holder of 19,750 in total.
Sutro Biopharma Inc (STRO) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.28 per share during the current fiscal year.
Sutro Biopharma Inc’s EPS increase for this current 12-month fiscal period is 41.25% and is forecasted to reach -1.10 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 32.73% through the next 5 years, which can be compared against the -4.05% growth it accomplished over the previous five years trading on the market.
Sutro Biopharma Inc (NASDAQ: STRO) Trading Performance Indicators
Let’s observe the current performance indicators for Sutro Biopharma Inc (STRO). It’s Quick Ratio in the last reported quarter now stands at 3.12. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.71.
In the same vein, STRO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.52, a figure that is expected to reach -0.39 in the next quarter, and analysts are predicting that it will be -1.10 at the market close of one year from today.
Technical Analysis of Sutro Biopharma Inc (STRO)
If we take a close look at the recent performances of Sutro Biopharma Inc (NASDAQ: STRO), its last 5-days Average volume was 2.66 million that shows progress from its year to date volume of 1.17 million. During the previous 9 days, stock’s Stochastic %D was recorded 21.00% While, its Average True Range was 55.27.
Raw Stochastic average of Sutro Biopharma Inc (STRO) in the period of the previous 100 days is set at 40.90%, which indicates a major fall in contrast to 50.62% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.0688 that was lower than 0.0704 volatility it exhibited in the past 100-days period.
